BLKB vs JNJ · P/E 9.1, rev $571.7M vs P/E 17, rev $49.37B
Blackbaud Inc (BLKB) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Blackbaud Inc (BLKB) is a software - application company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported BLKB revenue for 2026-06-30 was $571.7M. Net income was $66.5M. BLKB currently screens at market cap $1.23B and trailing P/E 9.1.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
BLKB currently screens at market cap $1.23B and trailing P/E 9.1. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the BLKB and JNJ stock pages for the full models.
Not investment advice.